{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:21:32Z","timestamp":1788402092626,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2018R1A2A2A05022021"],"award-info":[{"award-number":["NRF-2018R1A2A2A05022021"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ejon.2021.102066","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T21:48:34Z","timestamp":1637358514000},"page":"102066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Development of a prediction models for chemotherapy-induced adverse drug reactions: A retrospective observational study using electronic health records"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7164-7114","authenticated-orcid":false,"given":"Jeongah","family":"On","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeoun-Ae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8620-4925","authenticated-orcid":false,"given":"Sooyoung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejon.2021.102066_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/COC.0b013e318246b50d","article-title":"Predicting acute and persistent neuropathy associated with oxaliplatin","volume":"36","author":"Alejandro","year":"2013","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ejon.2021.102066_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1200\/jop.2005.1.2.57","article-title":"Electronic health records","volume":"1","author":"Ambinder","year":"2005","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.ejon.2021.102066_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/379870","article-title":"Neurological adverse effects in patients of advanced colorectal carcinoma treated with different schedules of FOLFOX","author":"Bano","year":"2013","journal-title":"Chemother Res Pract"},{"key":"10.1016\/j.ejon.2021.102066_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13555-016-0120-y","article-title":"Acute and chronic cutaneous reactions to ionizing radiation therapy","volume":"6","author":"Bray","year":"2016","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ejon.2021.102066_bib5","first-page":"314","article-title":"Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients","volume":"5","author":"Cascinu","year":"1997","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejon.2021.102066_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0971-5851.177015","article-title":"Chemotherapy-induced adverse drug reactions in oncology patients: a prospective observational survey","volume":"37","author":"Chopra","year":"2016","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"10.1016\/j.ejon.2021.102066_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/odi.12771","article-title":"Breast cancer patients have increased risk of developing mTOR inhibitor-associated stomatitis","volume":"24","author":"de Lima","year":"2018","journal-title":"Oral Dis."},{"key":"10.1016\/j.ejon.2021.102066_bib8","series-title":"Psycho-Oncology","first-page":"199","article-title":"Nausea and vomiting","author":"Dietrich","year":"2015"},{"key":"10.1016\/j.ejon.2021.102066_bib9","first-page":"W1","article-title":"Identifying patients at high risk for nausea and vomiting after chemotherapy: the development of a practical prediction tool. I. Acute nausea and vomiting","volume":"7","author":"Dranitsaris","year":"2009","journal-title":"J. Support Oncol."},{"key":"10.1016\/j.ejon.2021.102066_bib10","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/annonc\/mdx100","article-title":"The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting","volume":"28","author":"Dranitsaris","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejon.2021.102066_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/tpj.2012.2","article-title":"Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration","volume":"13","author":"Fernandez-Rozadilla","year":"2013","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.ejon.2021.102066_bib12","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1188\/05.ONF.1027-1035","article-title":"Chemotherapy-induced hypersensitivity reactions","volume":"32","author":"Gobel","year":"2005","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.ejon.2021.102066_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jamia\/ocw042","article-title":"Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review","volume":"24","author":"Goldstein","year":"2017","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"10.1016\/j.ejon.2021.102066_bib14","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1177\/0091270004268321","article-title":"Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy","volume":"44","author":"Heo","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejon.2021.102066_bib15","doi-asserted-by":"crossref","first-page":"101670","DOI":"10.1016\/j.ejon.2019.09.011","article-title":"Hand-foot syndrome and its impact on daily activities in breast cancer patients receiving docetaxel-based chemotherapy","volume":"43","author":"Hsu","year":"2019","journal-title":"Eur. J. Oncol. Nurs."},{"key":"10.1016\/j.ejon.2021.102066_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jjco\/hyaa186","article-title":"Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with lung cancer","volume":"51","author":"Imai","year":"2020","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.ejon.2021.102066_bib17","series-title":"2013 IEEE 15th International Conference on e-Health Networking, Applications and Services (Healthcom 2013)","first-page":"617","article-title":"Clinical-based prediction of side effects in colon cancer chemotherapy","author":"Kacimi","year":"2013"},{"key":"10.1016\/j.ejon.2021.102066_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2013.09.071","article-title":"Anticipatory nausea and vomiting due to chemotherapy","volume":"722","author":"Kamen","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejon.2021.102066_bib19","first-page":"437","article-title":"Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity","volume":"17","author":"Kearney","year":"2009","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejon.2021.102066_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00280-014-2526-5","article-title":"Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy","volume":"74","author":"Keefe","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejon.2021.102066_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000205263","article-title":"Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review","volume":"76","author":"Kim","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.ejon.2021.102066_bib22","first-page":"626","article-title":"The ten most common adverse drug reactions (ADRs) in oncology patients: do they matter to you?","volume":"12","author":"Lau","year":"2004","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.ejon.2021.102066_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1081-1206(10)60078-6","article-title":"Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents","volume":"102","author":"Lee","year":"2009","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejon.2021.102066_bib24","series-title":"2011 IEEE 13th International Conference on e-Health Networking, Applications and Services","first-page":"34","article-title":"A side-effects mapping model in patients with lung, colorectal and breast cancer receiving chemotherapy","author":"Mazzocco","year":"2011"},{"key":"10.1016\/j.ejon.2021.102066_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fphar.2016.00414","article-title":"Chemotherapy-induced constipation and diarrhea: pathophysiology, current and emerging treatments","volume":"7","author":"McQuade","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejon.2021.102066_bib26","first-page":"444","article-title":"Understanding the concept of chemotherapy-related nausea: the patient experience","volume":"17","author":"Molassiotis","year":"2008","journal-title":"Eur. J. Cancer Care"},{"key":"10.1016\/j.ejon.2021.102066_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00329","article-title":"Patient-related risk factors for chemotherapy-induced nausea and vomiting: a systematic review","volume":"11","author":"Mosa","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejon.2021.102066_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-6511-15-1","article-title":"Hypersensitivity to oxaliplatin: clinical features and risk factors","volume":"15","author":"Parel","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.ejon.2021.102066_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4040\/jkan.2013.43.2.154","article-title":"An introduction to logistic regression: from basic concepts to interpretation with particular attention to nursing domain","volume":"43","author":"Park","year":"2013","journal-title":"J. Korean Acad. Nurs."},{"key":"10.1016\/j.ejon.2021.102066_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184360","article-title":"Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study","volume":"12","author":"Pearce","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejon.2021.102066_bib31","first-page":"W9","article-title":"Identifying patients at high risk for nausea and vomiting after chemotherapy: the development of a practical validated prediction tool. II Delayed nausea and vomiting","volume":"7","author":"Petrella","year":"2009","journal-title":"J. Support Oncol."},{"key":"10.1016\/j.ejon.2021.102066_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1109\/JBHI.2016.2636665","article-title":"Deep learning for health informatics","volume":"21","author":"Rav\u00ec","year":"2017","journal-title":"IEEE J. Biomed. Health Inform"},{"key":"10.1016\/j.ejon.2021.102066_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00280-004-0924-9","article-title":"Incidence and risk factors for paclitaxel hypersensitivity during ovarian cancer chemotherapy","volume":"56","author":"Sendo","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejon.2021.102066_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4137\/CMO.S8360","article-title":"Clinical management of pain in advanced lung cancer","volume":"6","author":"Simmons","year":"2012","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.ejon.2021.102066_bib35","first-page":"130","article-title":"Decision tree methods: applications for classification and prediction","volume":"27","author":"Song","year":"2015","journal-title":"Shanghai Arch. Psychiatry"},{"key":"10.1016\/j.ejon.2021.102066_bib36","series-title":"Comparison of Computational Models in the Prediction of Adverse Drug Reaction","author":"Soyemi","year":"2015"},{"key":"10.1016\/j.ejon.2021.102066_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1758834009355164","article-title":"Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management","volume":"2","author":"Stein","year":"2010","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ejon.2021.102066_bib38","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0895-4356(96)00002-9","article-title":"Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes","volume":"49","author":"Tu","year":"1996","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ejon.2021.102066_bib39","series-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","first-page":"1161","article-title":"General principles in the pharmacotherapy of cancer","author":"Wellstein","year":"2018"},{"key":"10.1016\/j.ejon.2021.102066_bib40","first-page":"175","article-title":"Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors","volume":"20","author":"Wuketich","year":"2012","journal-title":"Support. Care Cancer"}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388921001745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388921001745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T20:23:03Z","timestamp":1761423783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388921001745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"alternative-id":["S1462388921001745"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2021.102066","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a prediction models for chemotherapy-induced adverse drug reactions: A retrospective observational study using electronic health records","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2021.102066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102066"}}